Invacare Corporation Comments on FDA Warning Letter Related to Its Documentation Procedures
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare responds to FDA warning letter regarding company documentation procedures.

FDA Releases CGMP Guidance For Small Business
The U.S. Food and Drug Administration has now published the long-awaited small entity compliance guide (SECG) for very small firms under the current Good Manufacturing Practices (cGMPs) for dietary supplements (21 CFR Part 111). The guidance was developed by the agency in conjunction with the staggered phase in of the rule based on firm size to limit disruption to small businesses. The SECG was ...